Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001062993-23-013030

Chief Financial Officer sold 38,000 shares at $7.16 ($272,080)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
PETERSON TYCHO Chief Financial Officer 2023-06-02 Sale −38,000 $7.16 $272,080 454,891 D: show line 1 in the form
Open-market sales · 38,000 sh · avg $7.16 · $272,080
Loading xslF345X04/form4.xml…